Cargando…
Association Between Multiple Lines of Active Therapy and Prognosis in Esophageal Squamous Cell Carcinoma
PURPOSE: Esophageal squamous cell carcinoma (ESCC) is a critical threat to health and life. More than half of ESCC patients have recurrent or metastatic disease. Most late-stage patients undergo first-line treatment but experience further progression. Many of these patients have good performance sta...
Autores principales: | Yang, Ying, Jia, Jun, Sun, Zhiwei, Liu, Chuanling, Xiao, Yanjie, Yu, Jing, Du, Feng, Zhang, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102887/ https://www.ncbi.nlm.nih.gov/pubmed/32273757 http://dx.doi.org/10.2147/CMAR.S242780 |
Ejemplares similares
-
Prognosis impact of clinical characteristics in patients with inoperable esophageal squamous cell carcinoma
por: Yang, Ying, et al.
Publicado: (2017) -
Phase 1 dose-escalation study of apatinib and irinotecan in esophageal squamous cell carcinoma patients
por: Jia, Jun, et al.
Publicado: (2021) -
Clinical significance of serum tumor markers for advanced gastric cancer with the first-line chemotherapy
por: Sun, Zhiwei, et al.
Publicado: (2019) -
Integrated bioinformatics analysis to identify key genes related to the prognosis of esophageal squamous cell carcinoma
por: Yang, Ying, et al.
Publicado: (2021) -
Nimotuzumab Plus Paclitaxel and Cisplatin as a 1(st)-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study
por: Zhang, Xiaodong, et al.
Publicado: (2019)